iShares iBonds Dec 2031 Term Corporate Getting Very Oversold
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 29 2024
0mins
Source: NASDAQ.COM
RSI Analysis: The iShares—iBonds—Dec 2031 Term Corporate has an RSI reading of 29.8, indicating potential exhaustion from heavy selling, while the S&P 500's RSI is at 61.3.
Stock Performance: IBDW shares have a 52-week range between $18.905 and $21.39, currently trading at $20.67, down about 0.2% for the day.
Analyst Views on IBDW
Wall Street analysts forecast IBDW stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IBDW is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 21.165
Low
Averages
High
Current: 21.165
Low
Averages
High
No data
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
